MGMT prevents cell killing by repairing O6-methylguanine (O6-MeG) cytotoxic DNA lesions induced by the cancer chemotherapy agents Temozolomide and Dacarbazine, and cytotoxic O6-chloroethylguanine lesions induced by cross-linking agents such as BCNU [3]. This evidence concerns the gene MGMT and cancer.